# Franklin Templeton's Biotech Investments: 11 Startups in Its Portfolio (2026) > The 11 Biotech startups Franklin Templeton has backed, by stage: $3.8B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/franklin-templeton-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 8 - [EQRx](https://millionrounds.com/company/eqrx) - [Candid Therapeutics](https://millionrounds.com/company/candid-therapeutics) - [Taysha Gene Therapies](https://millionrounds.com/company/taysha-gene-therapies) - [Allogene Therapeutics](https://millionrounds.com/company/allogene-therapeutics) - [Centessa Pharmaceuticals](https://millionrounds.com/company/centessa-pharmaceuticals) - [True North Therapeutics](https://millionrounds.com/company/true-north-therapeutics) - [Athira Pharma](https://millionrounds.com/company/athira-pharma) - [Nautilus Biotechnology](https://millionrounds.com/company/nautilus-biotechnology) ## Series C and later 3 - [Lycia Therapeutics](https://millionrounds.com/company/lycia-therapeutics) - [Metacrine](https://millionrounds.com/company/metacrine) - [Benchling](https://millionrounds.com/company/benchling) ## Segment by segment ### Stage not reported 8 startups · $3.3B raised - [**EQRx**](https://millionrounds.com/company/eqrx) EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable. United States $1.2B - [**Candid Therapeutics**](https://millionrounds.com/company/candid-therapeutics) Candid Therapeutics was a clinical-stage biotechnology company based in San Diego, California, founded in 2024. United States $875M - [**Taysha Gene Therapies**](https://millionrounds.com/company/taysha-gene-therapies) Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system. United States $400M - [**Allogene Therapeutics**](https://millionrounds.com/company/allogene-therapeutics) Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy. United States $310M - [**Centessa Pharmaceuticals**](https://millionrounds.com/company/centessa-pharmaceuticals) Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs. United States $250M - [**True North Therapeutics**](https://millionrounds.com/company/true-north-therapeutics) True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases. United States $142M - [**Athira Pharma**](https://millionrounds.com/company/athira-pharma) At Athira, we aim to restore neuronal health for those suffering from neurological diseases, including Alzheimer’s, Parkinson’s di United States $90M - [**Nautilus Biotechnology**](https://millionrounds.com/company/nautilus-biotechnology) Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome. United States $1.6M ### Series C and later 3 startups · $517M raised - [**Lycia Therapeutics**](https://millionrounds.com/company/lycia-therapeutics) Lycia Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California. United States $182M - [**Metacrine**](https://millionrounds.com/company/metacrine) Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs. United States $173M - [**Benchling**](https://millionrounds.com/company/benchling) Benchling is a cloud-based platform for biotechnology research and development and the only biology-first platform for scientific United States $162M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Franklin Templeton as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Franklin Templeton's AI portfolio** 27 startups · $49B](https://millionrounds.com/portfolio-maps/franklin-templeton-ai-portfolio)[Sector portfolio **Franklin Templeton's Fintech portfolio** 20 startups · $7.0B](https://millionrounds.com/portfolio-maps/franklin-templeton-fintech-portfolio)[Sector portfolio **Franklin Templeton's Web3 & Crypto portfolio** 15 startups · $1.4B](https://millionrounds.com/portfolio-maps/franklin-templeton-web3-crypto-portfolio)[Co-investors **Who invests with Franklin Templeton** 140 co-investors](https://millionrounds.com/portfolio-maps/franklin-templeton-co-investors)[Portfolio map **Franklin Templeton portfolio map** 107 startups · $102B](https://millionrounds.com/portfolio-maps/franklin-templeton-portfolio-map)[Sector portfolio **RA Capital Management's Biotech portfolio** 197 startups · $38B](https://millionrounds.com/portfolio-maps/ra-capital-management-biotech-portfolio) ## Raising from investors like Franklin Templeton? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)